Research

Uncertainty around NIH funding leaves Alzheimer’s studies in limbo

Francisco Rios was diagnosed with early Alzheimer’s at age 46. His wife, Zahydie Burgos Ribot, is now his caregiver. They recently visited Alaska, a destination on their bucket list. Courtesy Zahydie L. Burgos Ribot
View Content

Francisco Rios has been participating in a clinical trial conducted by Washington University in St. Louis in which he has been receiving the Alzheimer’s drug Leqembi paired with an experimental therapy called E2814, given as intravenous infusions, to help slow his Alzheimer’s symptoms.